Methylphenidate Safety Questions, Methylphenidate Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Methylphenidate side effects. Check out Health Surveys and Health Polls. If you have questions about Methylphenidate, you can post them to our Doctors or Ask Patient Community about Methylphenidate.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Methylphenidate
Methylphenidate Safety Reports
Total Methylphenidate reports: 77.Methylphenidate FDA safety alerts: 2005 .
Reported deaths: 5 Reported hospitalizations: 21.
Take Methylphenidate Side Effects Survey or Share Your Methylphenidate Story.
Reported Methylphenidate Side Effects: agitation, irritability, feeling abnormal, hyperhidrosis, anxiety, hypertension, aggression, abnormal behaviour, nausea, depression, asthenia.
More About Methylphenidate.
Showing 1-50 of 77 Next >
Methylphenidate Side Effects Report #5138196-9Physician from NETHERLANDS reported METHYLPHENIDATE problem on Aug 07, 2006. Male patient, weighting 209.4 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: depression. METHYLPHENIDATE dosage: unknown. Patient recovered.
Methylphenidate Side Effects Report #5138199-4
METHYLPHENIDATE problem was reported by a Physician from NETHERLANDS on Aug 23, 2006. Male patient, weighting 209.4 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: asthenia, depression, nausea. METHYLPHENIDATE dosage: unknown. During the same period patient was treated with CONCERTA. Patient recovered.
Methylphenidate Side Effects Report #5138201-X
Physician from NETHERLANDS reported METHYLPHENIDATE problem on Oct 17, 2006. Male patient, weighting 209.4 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: asthenia, decreased appetite, depression, hyperhidrosis, nausea. METHYLPHENIDATE dosage: unknown. During the same period patient was treated with CONCERTA. Patient recovered.
Methylphenidate Side Effects Report #5142082-8
METHYLPHENIDATE problem was reported by a Health Professional from UNITED STATES on Oct 30, 2006. Female patient, child 11 years of age, weighting 70.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, educational problem, memory impairment. METHYLPHENIDATE dosage: 10 MG INCE A DAY PO. Patient recovered.
Methylphenidate Side Effects Report #5147617-7
Health Professional from UNITED STATES reported METHYLPHENIDATE problem on Nov 08, 2006. Male patient, child 10 years of age, weighting 113.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anxiety. METHYLPHENIDATE dosage: 5MG PO Q4PM PRN. Patient recovered.
Methylphenidate Side Effects Report #5151156-7
METHYLPHENIDATE problem was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Male patient, child 10 years of age, weighting 113.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: anxiety, restlessness, tic. METHYLPHENIDATE dosage: 5 MG PO Q 4PM PRN. Patient recovered.
Methylphenidate Side Effects Report #5164878-9
Consumer or non-health professional from UNITED KINGDOM reported METHYLPHENIDATE problem on Nov 13, 2006. Male patient, 15 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: dizziness, eye rolling, feeling abnormal, hallucination, somnolence, syncope, tachycardia. METHYLPHENIDATE dosage: 18 MG /D PO. Patient recovered.
Methylphenidate Side Effects Report #5168811-5
METHYLPHENIDATE problem was reported by a Consumer or non-health professional from NETHERLANDS on Dec 06, 2006. Male patient, 31 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: agitation, blood ethanol increased, blood potassium decreased, blood pressure decreased, dyskinesia, feeling abnormal, hallucination, heart rate increased. METHYLPHENIDATE dosage: 150 MG/D. During the same period patient was treated with IBUPROFEN, ALCOHOL. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5376827-9
Health Professional from TURKEY reported METHYLPHENIDATE problem on June 22, 2007. Female patient, child 7 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: excessive masturbation, vulval haemorrhage. METHYLPHENIDATE dosage: 5 MG, BID. Patient recovered.
Methylphenidate Side Effects Report #5387289-X
METHYLPHENIDATE problem was reported by a Health Professional from NETHERLANDS on July 04, 2007. Male patient, child 7 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, crying, flushing, heart rate increased, hyperhidrosis. METHYLPHENIDATE dosage: 5 MG, BID. Patient recovered.
Methylphenidate Side Effects Report #5387297-9
Health Professional from NETHERLANDS reported METHYLPHENIDATE problem on July 04, 2007. Female patient, child 5 years of age, was diagnosed with attention deficit/hyperactivity disorder, otitis externa and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: crying, disorientation, hyperhidrosis. METHYLPHENIDATE dosage: 5 MG, BID. During the same period patient was treated with AMOXICILLIN. Patient recovered.
Methylphenidate Side Effects Report #5387310-9
METHYLPHENIDATE problem was reported by a Health Professional from NETHERLANDS on July 04, 2007. Male patient, child 11 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: anxiety, hyperhidrosis, hypertension, muscle spasms, nausea, palpitations, paraesthesia, peripheral coldness. METHYLPHENIDATE dosage: 7.5 MG/DAY. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5402003-7
Health Professional from TURKEY reported METHYLPHENIDATE problem on July 18, 2007. Male patient, child 5 years of age, was diagnosed with attention deficit/hyperactivity disorder, oppositional defiant disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, disturbance in attention, irritability. METHYLPHENIDATE dosage: 15 MG, DAILY; ORAL. During the same period patient was treated with RISPERIDONE. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5402004-9
METHYLPHENIDATE problem was reported by a Health Professional from TURKEY on July 18, 2007. Female patient, child 6 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: mania. METHYLPHENIDATE dosage: 15 MG, DAILY,ORAL. During the same period patient was treated with RISPERIDONE. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5402007-4
Health Professional from TURKEY reported METHYLPHENIDATE problem on July 18, 2007. Female patient, 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: agitation, discomfort, irritability. METHYLPHENIDATE dosage: 18 MG DAILY, ORAL. During the same period patient was treated with RISPERIDONE. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5412023-4
METHYLPHENIDATE problem was reported by a Health Professional from UNITED KINGDOM on Aug 06, 2007. Male patient, child 10 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: movement disorder, nervous system disorder, visual disturbance. METHYLPHENIDATE dosage: unknown. Patient recovered.
Methylphenidate Side Effects Report #5419652-2
Consumer or non-health professional from UNITED KINGDOM reported METHYLPHENIDATE problem on Aug 13, 2007. Male patient, child 10 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: movement disorder, nervous system disorder, visual disturbance. METHYLPHENIDATE dosage: unknown. Patient recovered.
Methylphenidate Side Effects Report #5424488-2
METHYLPHENIDATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 06, 2007. Male patient, child 10 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: movement disorder, nervous system disorder, visual field defect. METHYLPHENIDATE dosage: unknown. Patient recovered.
Methylphenidate Side Effects Report #5425824-3
Health Professional from UNITED STATES reported METHYLPHENIDATE problem on Aug 15, 2007. Male patient, child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: burning sensation, feeling abnormal, formication, hallucination, tactile, obsessive-compulsive disorder, somatic hallucination. METHYLPHENIDATE dosage: 10 MG, BID. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5426291-6
METHYLPHENIDATE problem was reported by a Health Professional from UNITED STATES on Aug 15, 2007. Male patient, child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: burning sensation, feeling abnormal, formication, hallucination, tactile, obsessive-compulsive disorder, somatic hallucination. METHYLPHENIDATE dosage: 10 MG, BID. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5436724-7
Physician from DOMINICAN REPUBLIC reported METHYLPHENIDATE problem on Aug 23, 2007. Male patient, child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: cardiomegaly, hypertension. METHYLPHENIDATE dosage: unknown. Patient recovered.
Methylphenidate Side Effects Report #5444308-X
METHYLPHENIDATE problem was reported by a Health Professional from NETHERLANDS on Aug 23, 2007. Male patient, child 11 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: anxiety, hyperhidrosis, hypertension, muscle spasms, nausea, palpitations, paraesthesia, peripheral coldness. METHYLPHENIDATE dosage: 15 MG, DAILY. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5444411-4
Health Professional from UNITED KINGDOM reported METHYLPHENIDATE problem on Aug 29, 2007. Male patient, 15 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, dizziness. METHYLPHENIDATE dosage: 36MG/UNK. Patient recovered.
Methylphenidate Side Effects Report #5458018-6
METHYLPHENIDATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 30, 2007. Male patient, 15 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dizziness postural. METHYLPHENIDATE dosage: 36 MG. Patient recovered.
Methylphenidate Side Effects Report #5463334-8
Health Professional from UNITED STATES reported METHYLPHENIDATE problem on Sept 11, 2007. Female patient, 38 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, therapeutic response unexpected. METHYLPHENIDATE dosage: 10 MG, BID. During the same period patient was treated with ASCORBIC ACID, DIAZEPAM, GLIPIZIDE, INSULIN, METAXALONE, METFORMIN, ALPRAZOLAM, BISACODYL. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5463355-5
METHYLPHENIDATE problem was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Female patient, 38 years of age, was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, therapeutic response unexpected. METHYLPHENIDATE dosage: 10 MG, BID. During the same period patient was treated with ASCORBIC ACID, DIAZEPAM, GLIPIZIDE, INSULIN, METAXALONE, METFORMIN, ALPRAZOLAM, BISACODYL. Patient was hospitalized. Patient recovered.
Methylphenidate Side Effects Report #5470481-3
Physician from UNITED STATES reported METHYLPHENIDATE problem on Sept 27, 2007. Male patient, weighting 212.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with METHYLPHENIDATE. After drug was administered, patient experienced the following problems/side effects: palpitations. METHYLPHENIDATE dosage: unknown. Patient recovered.
Showing 1-50 of 77 Next >
Drug Information: Methylphenidate
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682188.html
(meth il fen' i date)IMPORTANT WARNING:
| Methylphenidate can be habit-forming. Do not take a larger dose, take it more often, take it for a longer time, or take it in a different way than prescribed by your doctor. If you take too much methylphenidate, you may find that the medication no longer controls your symptoms, you may feel a need to take large amounts of the medication, and you may experience unusual changes in your behavior. Tell your doctor if you drink or have ever drunk large amounts of alcohol, use or have ever used street drugs, or have overused prescription medications.Do not stop taking methylphenidate without talking to your doctor, especially if you have overused the medication. Your doctor will probably decrease your dose gradually and monitor you carefully during this time. You may develop severe depression if you suddenly stop taking methylphenidate after overusing it.Your doctor or pharmacist will give you the manufacturer’s patient information sheet (Medication Guide) when you begin treatment with methylphenidate and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/cder) or the manufacturer's website to obtain the Medication Guide. |
Why is this medication prescribed?
Methylphenidate is used as part of a treatment program for attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age). Methylphenidate (Ritalin, Ritalin SR, Methylin, Methylin ER) is also used to treat narcolepsy (a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep). Methylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by changing the amounts of certain natural substances in the brain.
How should this medicine be used?
Methylphenidate comes as an immediate-release tablet, a chewable tablet, a solution (liquid); an intermediate-acting (extended-release) tablet; a long-acting (extended-release) capsule, and a long-acting (extended release) tablet. The long-acting tablet and capsules supply some medication right away and release the remaining amount as a steady dose of medication over a long time.All of these forms of methylphenidate are taken by mouth. The regular tablets (Ritalin, Methylin), chewable tablets (Methylin), and solution (Methylin) are usually taken 2 to 3 times a day, preferably 35-40 minutes before meals. The last dose should be taken at least several hours before bedtime. The intermediate-acting extended release tablets (Ritalin SR, Metadate ER, Methylin ER) are usually taken once a day in the morning with or without food. The long-acting extended release capsule (Metadate CD) is usually taken once a day before breakfast; the long-acting extended-release tablet (Concerta) and capsule (Ritalin LA) are usually taken once a day in the morning with or without food.
Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take methylphenidate exactly as directed.
You should thoroughly chew the chewable tablets and then drink a full glass (at least 8 ounces) of water or other liquid. If you take the chewable tablet without enough liquid, the tablet may swell and block your throat and may cause you to choke. If you have chest pain, vomiting, or trouble swallowing or breathing after taking the chewable tablet, you should call your doctor or get emergency medical treatment immediately.
Swallow the intermediate acting and long-acting extended-release tablets and capsules whole; do not split, chew, or crush them.However, if you cannot swallow the long-acting capsules (Metadate CD, Ritalin LA), you may carefully open the capsules and sprinkle the entire contents on a tablespoon of cool or room temperature applesauce. Swallow (without chewing) this mixture immediately after preparation and then drink a glass of water to make sure you have swallowed all of the medicine. Do not store the mixture for future use.
Your doctor may start you on a low dose of methylphenidate and gradually increase your dose, not more often than once every week.
Your condition should improve during your treatment. Call your doctor if your symptoms worsen at any time during your treatment or do not improve after one month.
Your doctor may tell you to stop taking methylphenidate from time to time to see if the medication is still needed. Follow these directions carefully.
Other uses for this medicine
Methylphenidate should not be used to treat depression or excessive tiredness that is not caused by narcolepsy.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking methylphenidate,
- tell your doctor and pharmacist if you are allergic to methylphenidate or any other medications.
- tell your doctor if you are taking monoamine oxidase (MAO) inhibitors, including isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl), and tranylcypromine (Parnate), or have stopped taking them during the past 14 days. Your doctor will probably tell you not to take methylphenidate until at least 14 days have passed since you last took an MAO inhibitor.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: antidepressants ('mood elevators'); anticoagulants ('blood thinners') such as warfarin (Coumadin); clonidine (Catapres); guanabenz; medications for seizures such as phenobarbital, phenytoin (Dilantin), and primidone (Mysoline); and methyldopa (Aldomet). If you are taking Ritalin LA, also tell your doctor if you take antacids.
- tell your doctor if you or anyone in your family has or has ever had Tourette's syndrome (a condition characterized by the need to perform repeated motions or to repeat sounds or words), facial or motor tics (repeated uncontrollable movements), or verbal tics (repetition of sounds or words that is hard to control), Also tell your doctor if you have glaucoma, or feelings of anxiety, tension, or agitation. Your doctor will probably tell you not to take methylphenidate.
- tell your doctor if anyone in your family has or has ever had an irregular heartbeat or has died suddenly. Also tell your doctor if you have recently had a heart attack and if you have or have ever had a heart defect, high blood pressure, an irregular heartbeat, heart or blood vessel disease, or other heart problems. Your doctor will probably examine you to see if your heart and blood vessels are healthy. Your doctor may tell you not to take methylphenidate if you have a heart condition or if there is a high risk that you may develop a heart condition.
- also tell your doctor if you have or ever have had seizures, or mental illness. If you are taking the chewable tablets, tell your doctor if you have trouble swallowing or if you have phenylketonuria (PKU, a disease in which you must avoid certain foods). If you are taking the long-acting extended-release tablet (Concerta), tell your doctor if you have a a narrowing or blockage of your digestive system.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking methylphenidate, call your doctor.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking methylphenidate.
- you should know that methylphenidate should be used as part of a total treatment program for ADHD, which may include counseling and special education. Make sure to follow all of your doctor's and/or therapist's instructions.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it and take any remaining doses for that day at evenly spaced intervals, but do not take a dose at or near bedtime. However, if you remember a missed dose when it is almost time for your next scheduled dose, skip the missed dose. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Methylphenidate may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- nervousness
- difficulty falling asleep or staying asleep
- dizziness
- nausea
- vomiting
- loss of appetite
- stomach pain
- diarrhea
- headache
- painful menstruation
Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:
- fast, pounding, or irregular heartbeat
- chest pain
- shortness of breath
- excessive tiredness
- slow or difficult speech
- dizziness or faintness
- weakness or numbness of an arm or leg
- seizures
- changes in vision or blurred vision
- agitation
- abnormal thoughts
- hallucinating (seeing things or hearing voices that do not exist)
- motor tics or verbal tics
- depression
- mood changes
- fever
- sore throat
- unusual bleeding or bruising
- muscle or joint pain
- hives
- rash
- itching
- difficulty breathing or swallowing
Methylphenidate may cause sudden death in children and teenagers with heart defects or serious heart problems. This medication also may cause sudden death, heart attack or stroke in adults, especially adults with heart defects or serious heart problems. Talk to your doctor about the risks of taking this medication.
Methylphenidate may slow children's growth or weight gain. Your child's doctor will watch his or her growth carefully. Talk to your child's doctor if you have concerns about your child's growth or weight gain while he or she is taking this medication. Talk to your child's doctor about the risks of giving methylphenidate to your child.
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature, away from light and excess heat and moisture (not in the bathroom). Store methylphenidate in a safe place so that no one else can take it accidentally or on purpose. Keep track of how many tablets or capsules are left so you will know if any are missing. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- vomiting
- agitation
- shaking of hands that you cannot control
- muscle twitching
- seizures
- loss of consciousness
- inappropriate happiness
- confusion
- hallucinating (seeing things or hearing voices that do not exist)
- sweating
- flushing
- headache
- fever
- fast, pounding, or irregular heartbeat
- widening of pupils (black circles in the middle of the eyes)
- dry mouth
What other information should I know?
If you are taking methylphenidate long-acting tablets (Concerta), you may notice something that looks like a tablet in your stool. This is just the empty tablet shell, and this does not mean that you did not get your complete dose of medication.
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your response to methylphenidate.
Do not let anyone else take your medication. This prescription is not refillable. Be sure to schedule appointments with your doctor on a regular basis so that you do not run out of medication.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
|
Other name(s):
|